Financhill
Back

Verint Systems Vs. Viking Therapeutics Industry Stock Comparison

Sell
48

VRNT
Verint Systems

Last Price:
32.20
Seasonality Move:
-1.59%
Sell
44

VKTX
Viking Therapeutics

Last Price:
52.96
Seasonality Move:
1.76%
Sell
48
Verint Systems (VRNT) is a Sell

Is Verint Systems a Buy, Sell or Hold?

  • The current Verint Systems [VRNT] share price is $32.69. The Score for VRNT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VRNT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRNT Stock Price Chart

What is Verint Systems's stock price today?

  • The Verint Systems share price today is $32.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRNT is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $50.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.35 Buy
Relative Strength Index (14 RSI): 47.29 Sell
Chaikin Money Flow: 932477 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.36 - 35.96) Sell
Bollinger Bands (100): (29.74 - 33.42) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.32 Sell
Relative Strength Index (14 RSI): 38.16 Sell
Chaikin Money Flow: 2857375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.57 - 61.31) Sell
Bollinger Bands (100): (46.52 - 79.44) Sell

VRNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.79 Sell
20-day SMA: 33.78 Sell
50-day SMA: 32.07 Buy
200-day SMA: 28 Buy
8-day EMA: 33.49 Sell
20-day EMA: 33.58 Sell
50-day EMA: 32.57 Buy
200-day EMA: 30.91 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.48 Buy
20-day SMA: 54.1 Sell
50-day SMA: 63.93 Sell
200-day SMA: 39 Buy
8-day EMA: 50.61 Buy
20-day EMA: 54.34 Sell
50-day EMA: 59.63 Sell
200-day EMA: 45.62 Buy

Verint Systems Earnings Growth & VRNT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.15 per share, and an increase next year of $0.25 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

Verint Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):